885671-72-7

Upstream product

• 2936-70-1 (2R,3S,4S,5R,6S)-2-Hydroxymethyl-6-phenylsulfanyl-tetrahydro-pyran-3,4,5-triol 
• 196868-07-2 1,2-O-isopropylidene-5-O-(tert-butyl)dimethylsilyl-α-D-ribofuranoside 
• 518332-44-0 5-O-tert-butyldimethylsilyl-3-O-[2,6-di-O-benzyl-3,4-O-[(2S,3S)-2,3-dimethoxybutan-2,3-yl]-α-D-glucopyranosyl]-1,2-O-isopropylidene-α-D-ribofuranose 
• 518332-60-0 3-O-[2,6-di-O-benzyl-3,4-O-[(2S,3S)-2,3-dimethoxybutan-2,3-yl]-α-D-glucopyranosyl]-1,2-O-isopropylidene-5-phenyl-α-D-ribofuranose 
• 518332-46-2 5-deoxy-3-O-[2,6-di-O-benzyl-3,4-O-[(2S,3S)-2,3-dimethoxybutan-2,3-yl]-5-phenyl-α-D-glucopyranosyl]-1,2-O-isopropylidene-α-D-ribofuranose 
• 518332-41-7 2,6-di-O-benzyl-3,4-O-[(2S,3S)-2,3-dimethoxybutan-2,3-yl]-1-phenylsulfinyl-β-D-glucopyranoside 
• 518332-50-8 Isobutyric acid (2R,3R,4R,5R)-2-(6-benzoylamino-purin-9-yl)-5-benzyl-4-((2R,3R,4S,5R,6R)-3-benzyloxy-6-benzyloxymethyl-4,5-bis-isobutyryloxy-tetrahydro-pyran-2-yloxy)-tetrahydro-furan-3-yl ester 
• 100-39-0 benzyl bromide 
• 518332-48-4 5-deoxy-5-phenyl-3-O-(2,6-di-O-benzyl-3,4-di-O-isobutyryl-α-D-glucopyranosyl)-1,2-O-isobutyryl-α-D-ribofuranose 
• 795305-88-3 phenyl 2,6-di-O-benzyl-3,4-O-[(2S,3S)-2,3-dimethoxybutan-2,3-yl]-1-thio-β-D-glucopyranoside 
• 795305-86-1 phenyl 3,4-O-[(2S,3S)-2,3-dimethoxybutan-2,3-yl]-1-thio-β-D-glucopyranoside 
• 295320-98-8 3-O-[2,6-di-O-benzyl-3,4-O-[(2S,3S)-2,3-dimethoxybutan-2,3-yl]-α-D-glucopyranosyl]-1,2-O-isopropylidene-α-D-ribofuranose 
• 885671-71-6 Isobutyric acid (3R,4R,5R)-5-benzyl-4-((2R,3R,4S,5R,6R)-3-benzyloxy-6-benzyloxymethyl-4,5-bis-isobutyryloxy-tetrahydro-pyran-2-yloxy)-2-isobutyryloxy-tetrahydro-furan-3-yl ester 

Downstream Products

• 885671-73-8 C₆₀H₆₀N₅O₁₇P₃ 

Relevant academic research and scientific papers

Design and synthesis of 5′-deoxy-5′-phenyladenophostin A, a highly potent IP3 receptor ligand

5′-Deoxy-5′-phenyladenophostin A (5), designed as a useful IP3 receptor ligand based on the previous structure-activity relationship studies, was successfully synthesized via two key stereoselective glycosidation steps. This compound proved to

Synthesis of adenophostin A analogues conjugating an aromatic group at the 5′-position as potent IP3 receptor ligands

Previous structure-activity relationship studies of adenophostin A, a potent IP3 receptor agonist, led us to design the novel adenophostin A analogues 5a-c, conjugating an aromatic group at the 5′-position to develop useful IP3 recep